BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hackett G, Jones PW, Strange RC, Ramachandran S. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes 2017; 8(3): 104-111 [PMID: 28344753 DOI: 10.4239/wjd.v8.i3.104]
URL: https://www.wjgnet.com/1948-9358/full/v8/i3/104.htm
Number Citing Articles
1
Farid Saad. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and ObesityAdvances in Experimental Medicine and Biology 2017; 1043: 527 doi: 10.1007/978-3-319-70178-3_23
2
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, Giovanni Rossini, Virginia Zamponi, Soraya Olana, Antongiulio Faggiano, Paolo Pozzilli, Andrea M. Isidori, Daniele Gianfrilli. Erectile dysfunction and diabetes: A melting pot of circumstances and treatmentsDiabetes/Metabolism Research and Reviews 2022; 38(2) doi: 10.1002/dmrr.3494
3
Sudarshan Ramachandran, Carola S. König, Geoffrey Hackett, Mark Livingston, Richard C. Strange. Managing Clinical Heterogeneity: An Argument for Benefit-Based Action LimitsJournal of Engineering and Science in Medical Diagnostics and Therapy 2018; 1(3) doi: 10.1115/1.4039561
4
Zhonglin Cai, Jianzhong Zhang, Hongjun Li. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular DiseasesCardiovascular Drugs and Therapy 2019; 33(1): 119 doi: 10.1007/s10557-019-06851-7
5
Michael Kirby, Geoffrey Hackett, Sudarshan Ramachandran. Testosterone and the HeartEuropean Cardiology Review 2019; 14(2): 103 doi: 10.15420/ecr.2019.13.1
6
Geoff Hackett, Michael Kirby, David Edwards, Thomas Hugh Jones, Kevan Wylie, Nick Ossei-Gerning, Janine David, Asif Muneer. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, with Statements for UK PracticeThe Journal of Sexual Medicine 2017; 14(12): 1504 doi: 10.1016/j.jsxm.2017.10.067
7
Irina Khripun, Sergey Vorobyev, Igor Belousov, Michel Kogan, Michael Zitzmann. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trialThe Aging Male 2019; 22(4): 241 doi: 10.1080/13685538.2018.1506918
8
Sudarshan Ramachandran, Geoffrey I. Hackett, Richard C. Strange. Testosterone replacement therapy: Pre‐treatment sex hormone‐binding globulin levels and age may identify clinical subgroupsAndrology 2020; 8(5): 1222 doi: 10.1111/andr.12813
9
Yuliya Tishova, Svetlana Kalinchenko, George Mskhalaya, Geoffrey Hackett, Mark Livingston, Carola König, Richard Strange, Michael Zitzmann, Amar Mann, Amro Maarouf, Sudarshan Ramachandran. Testosterone therapy reduces insulin resistance in men with adult‐onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open‐label phaseDiabetes, Obesity and Metabolism 2024; 26(6): 2147 doi: 10.1111/dom.15520
10
S. Ramachandran, R. C. Strange, A. A. Fryer, F. Saad, G. I. Hackett. The association of sex hormone‐binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetesAndrology 2018; 6(6): 846 doi: 10.1111/andr.12520
11
Sumon Roy, Robert A. Kloner, Fadi N. Salloum, Ion S. Jovin. Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and SafetyCardiovascular Drugs and Therapy 2023; 37(4): 793 doi: 10.1007/s10557-021-07275-y
12
Mark D. Peterson, Aleksandr Belakovskiy, Ryan McGrath, Joshua F. Yarrow. Testosterone Deficiency, Weakness, and Multimorbidity in MenScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24347-6
13
Richard C. Strange, Carola S. König, Adeeba Ahmed, Geoff Hackett, Ahmad Haider, Karim S. Haider, Pieter Desnerck, Farid Saad, Nathan Lorde, Amro Maarouf, Sudarshan Ramachandran. Testosterone Therapy: Increase in Hematocrit is Associated with Decreased MortalityAndrogens: Clinical Research and Therapeutics 2021; 2(1): 150 doi: 10.1089/andro.2021.0019
14
Katya B. Rubinow, Jing H. Chao, Derek Hagman, Mario Kratz, Brian Van Yserloo, Nilesh W. Gaikwad, John K. Amory, Stephanie T. Page. Circulating sex steroids coregulate adipose tissue immune cell populations in healthy menAmerican Journal of Physiology-Endocrinology and Metabolism 2017; 313(5): E528 doi: 10.1152/ajpendo.00075.2017
15
Daria Khaltourina, Yuri Matveyev, Aleksey Alekseev, Franco Cortese, Anca Ioviţă. Aging Fits the Disease Criteria of the International Classification of DiseasesMechanisms of Ageing and Development 2020; 189: 111230 doi: 10.1016/j.mad.2020.111230
16
Robert A. Kloner, Irwin Goldstein, Michael G. Kirby, John D. Parker, Richard Sadovsky. Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the MarketSexual Medicine Reviews 2018; 6(4): 583 doi: 10.1016/j.sxmr.2018.03.008
17
Mark Livingston, Paul Downie, Geoff Hackett, Rachel Marrington, Adrian Heald, Sudarshan Ramachandran. An audit of the measurement and reporting of male testosterone levels in UK clinical biochemistry laboratoriesInternational Journal of Clinical Practice 2020; 74(11) doi: 10.1111/ijcp.13607
18
Tobias S. Köhler, Robert A. Kloner, Raymond C. Rosen, Arthur L. Burnett, Michael J. Blaha, Peter Ganz, Irwin Goldstein, Noel N. Kim, Tom Lue, Kevin T. McVary, John P. Mulhall, Sharon J. Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira D. Sharlip, Martin Miner. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular DiseaseMayo Clinic Proceedings 2024; 99(9): 1500 doi: 10.1016/j.mayocp.2024.06.002
19
Geoffrey Hackett. Type 2 Diabetes and Testosterone TherapyThe World Journal of Men's Health 2019; 37(1): 31 doi: 10.5534/wjmh.180027
20
Carola S. König, Stavroula Balabani, Geoffrey I. Hackett, Richard C. Strange, Sudarshan Ramachandran. Testosterone Therapy: An Assessment of the Clinical Consequences of Changes in Hematocrit and Blood Flow CharacteristicsSexual Medicine Reviews 2019; 7(4): 650 doi: 10.1016/j.sxmr.2019.01.003
21
Adrian H. Heald, Ghasem Yadegar far, Mark Livingston, Helene Fachim, Mark Lunt, Ram Prakash Narayanan, Kirk Siddals, Gabriela Moreno, Richard Jones, Nagaraj Malipatil, Martin Rutter, Martin Gibson, Rachelle Donn, Geoff Hackett, Hugh Jones. Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort studyCardiovascular Endocrinology & Metabolism 2020; 10(1): 37 doi: 10.1097/XCE.0000000000000230
22
Robert A Kloner, Arthur L Burnett, Martin Miner, Michael J Blaha, Peter Ganz, Irwin Goldstein, Noel N Kim, Tobias Kohler, Tom Lue, Kevin T McVary, John P Mulhall, Sharon J Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira D Sharlip, Raymond C Rosen. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac healthThe Journal of Sexual Medicine 2024; 21(2): 90 doi: 10.1093/jsxmed/qdad163
23
Stergios Soulaidopoulos, Dimitrios Terentes-Printzios, Nikolaos Ioakeimidis, Konstantinos P Tsioufis, Charalambos Vlachopoulos. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysisEuropean Heart Journal - Cardiovascular Pharmacotherapy 2024; 10(5): 403 doi: 10.1093/ehjcvp/pvae029
24
Mark Livingston, Adrian Heald, Geoffrey Hackett, Harishnath Ramachandran, Sudarshan Ramachandran. Is there an association between daylight hours and serum testosterone levels in men?The Aging Male 2024; 27(1) doi: 10.1080/13685538.2024.2409189
25
Sudarshan Ramachandran, Geoffrey I. Hackett, Richard C. Strange. Sex Hormone Binding Globulin: A Review of its Interactions With Testosterone and Age, and its Impact on Mortality in Men With Type 2 DiabetesSexual Medicine Reviews 2019; 7(4): 669 doi: 10.1016/j.sxmr.2019.06.006
26
C. Burté, H. Lejeune, A. Faix, P. Desvaux, T. Almont, B. Cuzin, E. Huyghe. Les recommandations pour la prise en charge du déficit en testostéroneSexologies 2021; 30(3): 149 doi: 10.1016/j.sexol.2021.06.006
27
Jong-Dai Kim. Diabetes and Sexual DysfunctionThe Journal of Korean Diabetes 2023; 24(1): 18 doi: 10.4093/jkd.2023.24.1.18
28
Shikhar Tripathi, M. Elakiya, Alka Mishra, Dhastagir Sultan Sherrif. A perspective on diabetes-related hypogonadismCurrent Medicine Research and Practice 2021; 11(2): 88 doi: 10.4103/cmrp.cmrp_3_21
29
Steven G. Chrysant, George S. Chrysant. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosteroneHospital Practice 2018; 46(2): 47 doi: 10.1080/21548331.2018.1445405
30
Amar Mann, Richard C Strange, Carola S König, Geoffrey Hackett, Ahmad Haider, Karim Sultan Haider, Peter Desnerck, Sudarshan Ramachandran. Testosterone replacement therapy: association with mortality in high‐risk patient subgroupsAndrology 2024; 12(6): 1389 doi: 10.1111/andr.13582
31
C. Burte, H. Lejeune, A. Faix, P. Desvaux, T. Almont, B. Cuzin, E. Huyghe. Recommandations pratiques pour la prise en charge du déficit en testostéroneProgrès en Urologie 2021; 31(8-9): 458 doi: 10.1016/j.purol.2020.09.026
32
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange, Sudarshan Ramachandran. Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile FunctionThe World Journal of Men's Health 2020; 38(1): 68 doi: 10.5534/wjmh.180052M
33
Mark Livingston, Anura Kalansooriya, Andrew J. Hartland, Sudarshan Ramachandran, Adrian Heald. Serum testosterone levels in male hypogonadism: Why and when to check-A reviewInternational Journal of Clinical Practice 2017; 71(11): e12995 doi: 10.1111/ijcp.12995
34
Jose Antonio Santos-Marcos, Marina Mora-Ortiz, Manuel Tena-Sempere, Jose Lopez-Miranda, Antonio Camargo. Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseasesBiology of Sex Differences 2023; 14(1) doi: 10.1186/s13293-023-00490-2
35
Robert A. Kloner, Eric Stanek, Karishma Desai, Christopher L. Crowe, Kathryn Paige Ball, Aaron Haynes, Raymond C. Rosen. The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunctionClinical Cardiology 2024; 47(2) doi: 10.1002/clc.24234
36
Amar Mann, Richard C. Strange, Geoffrey Hackett, Carola König, Sudarshan Ramachandran. Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related conditionExploration of Endocrine and Metabolic Diseases 2024; 1(3): 83 doi: 10.37349/eemd.2024.00010
37
G. Hackett, N. Cole, A. Saghir, P. Jones, R. C. Strange, S. Ramachandran. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30‐week randomized placebo‐controlled studyAndrology 2017; 5(5): 905 doi: 10.1111/andr.12399
38
Nathan Lorde, Amro Maarouf, Richard C. Strange, Carola S. König, Geoff Hackett, Ahmad Haider, Karim Sultan Haider, Pieter Desnerck, Farid Saad, Sudarshan Ramachandran. Testosterone Therapy in Adult-Onset Testosterone Deficiency: Hematocrit and Hemoglobin ChangesAndrogens: Clinical Research and Therapeutics 2021; 2(1): 141 doi: 10.1089/andro.2021.0013
39
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange, Sudarshan Ramachandran. Long‐term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factorsBJU International 2019; 123(3): 519 doi: 10.1111/bju.14536
40
Federica Barbagallo, Federica Campolo, Edoardo Franceschini, Elena Crecca, Riccardo Pofi, Andrea M. Isidori, Mary Anna Venneri. PDE5 Inhibitors in Type 2 Diabetes Cardiovascular ComplicationsEndocrines 2020; 1(2): 90 doi: 10.3390/endocrines1020009
41
Raymond C Rosen, Martin Miner, Arthur L Burnett, Michael J Blaha, Peter Ganz, Irwin Goldstein, Noel Kim, Tobias Kohler, Tom Lue, Kevin McVary, John Mulhall, Sharon J Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira Sharlip, Robert A Kloner. Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposiumSexual Medicine Reviews 2024; 12(4): 681 doi: 10.1093/sxmrev/qeae043